NPI: 1598748782 · MONROE, LA 71203 · Clinical Medical Laboratory · NPI assigned 11/22/2005
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VP) |
| NPI Enumeration Date | 11/22/2005 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,816 | $137K |
| 2019 | 24,640 | $180K |
| 2020 | 47,679 | $245K |
| 2021 | 106,042 | $485K |
| 2022 | 121,632 | $602K |
| 2023 | 140,100 | $905K |
| 2024 | 107,272 | $832K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,299 | 2,100 | $385K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 78,841 | 66,474 | $305K |
| 80050 | General health panel | 11,743 | 10,488 | $229K |
| 80053 | Comprehensive metabolic panel | 55,618 | 44,411 | $196K |
| 87507 | 813 | 731 | $186K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4,653 | 3,921 | $144K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 53,482 | 39,347 | $143K |
| 80061 | Lipid panel | 29,296 | 25,500 | $139K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9,375 | 8,127 | $121K |
| 87186 | 27,125 | 23,791 | $118K | |
| 87088 | 28,032 | 24,177 | $105K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4,551 | 4,146 | $103K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4,552 | 4,147 | $103K |
| 87081 | 21,868 | 20,378 | $101K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 23,570 | 20,332 | $66K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2,998 | 2,721 | $64K |
| 0099U | 429 | 420 | $56K | |
| 84443 | Thyroid stimulating hormone (TSH) | 13,574 | 11,853 | $48K |
| 87070 | 9,843 | 8,640 | $46K | |
| 87077 | 10,954 | 9,639 | $44K | |
| 87486 | 1,854 | 1,684 | $43K | |
| 87581 | 1,854 | 1,684 | $43K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,356 | 1,784 | $42K |
| 81001 | 24,505 | 21,772 | $39K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 527 | 486 | $38K |
| 82728 | 4,782 | 4,206 | $32K | |
| 85027 | 15,679 | 12,694 | $27K | |
| 82607 | 4,366 | 3,861 | $26K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,667 | 1,500 | $25K |
| 83020 | 2,174 | 1,734 | $20K | |
| 84153 | 2,603 | 2,273 | $20K | |
| 84439 | 4,974 | 4,275 | $18K | |
| 83735 | 5,613 | 4,252 | $18K | |
| 82746 | 2,858 | 2,530 | $17K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,827 | 6,904 | $16K |
| 84702 | 1,629 | 1,314 | $12K | |
| 82784 | 1,498 | 1,115 | $12K | |
| 85045 | 4,737 | 3,874 | $12K | |
| 83550 | 2,901 | 2,539 | $11K | |
| 83615 | 2,742 | 2,277 | $10K | |
| 83540 | 3,814 | 3,309 | $10K | |
| 86803 | 1,402 | 1,232 | $10K | |
| 82378 | 1,137 | 954 | $9K | |
| 84436 | 3,061 | 2,557 | $9K | |
| 86762 | 995 | 834 | $8K | |
| 0097U | 58 | 57 | $7K | |
| 84479 | 2,572 | 2,148 | $7K | |
| 82570 | 3,172 | 2,814 | $7K | |
| 82043 | 2,763 | 2,472 | $7K | |
| 85610 | 6,585 | 3,881 | $7K | |
| 84403 | 439 | 404 | $6K | |
| 87427 | 971 | 874 | $6K | |
| 84100 | 2,327 | 1,506 | $6K | |
| 86140 | 3,030 | 2,301 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 643 | 597 | $6K |
| 86850 | 1,012 | 858 | $5K | |
| 87045 | 982 | 888 | $5K | |
| 87046 | 978 | 887 | $5K | |
| 84550 | 2,128 | 1,717 | $5K | |
| 85730 | 2,353 | 1,911 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 203 | 197 | $4K |
| 81003 | 4,993 | 4,190 | $4K | |
| 85652 | 3,451 | 2,694 | $4K | |
| 82248 | 1,568 | 1,331 | $3K | |
| 84134 | 2,631 | 2,198 | $3K | |
| 84481 | 343 | 322 | $3K | |
| 80074 | 155 | 129 | $3K | |
| 86901 | 1,400 | 1,219 | $2K | |
| 86900 | 1,402 | 1,219 | $2K | |
| 83880 | 478 | 391 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 47 | 45 | $2K |
| 80164 | 2,506 | 2,127 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 82 | 80 | $2K |
| 84165 | 555 | 506 | $2K | |
| 86592 | 748 | 670 | $2K | |
| 80177 | 1,532 | 1,309 | $2K | |
| 83690 | 493 | 437 | $2K | |
| 80069 | 897 | 766 | $2K | |
| 82565 | 607 | 494 | $1K | |
| 86300 | 134 | 124 | $1K | |
| 83002 | 90 | 80 | $1K | |
| 83001 | 87 | 80 | $1K | |
| 82947 | 677 | 555 | $1K | |
| 84520 | 520 | 428 | $997.83 | |
| 80051 | 266 | 213 | $974.85 | |
| 82150 | 247 | 213 | $825.03 | |
| 87040 | 154 | 128 | $818.75 | |
| 80076 | 340 | 303 | $747.26 | |
| 83525 | 138 | 109 | $703.58 | |
| 82247 | 311 | 232 | $696.37 | |
| 84156 | 376 | 317 | $665.71 | |
| 36415 | Collection of venous blood by venipuncture | 5,939 | 5,344 | $664.43 |
| 84155 | 811 | 698 | $647.64 | |
| 82550 | 312 | 220 | $599.67 | |
| 83021 | 42 | 40 | $590.01 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 26 | 26 | $575.51 |
| 85018 | 670 | 480 | $468.45 | |
| 81025 | 96 | 86 | $448.06 | |
| 87205 | 239 | 212 | $441.93 | |
| 86038 | 59 | 57 | $401.06 | |
| 84132 | 820 | 602 | $369.47 | |
| 87340 | 77 | 64 | $346.68 | |
| 85014 | 492 | 342 | $302.69 | |
| 86696 | 17 | 17 | $216.08 | |
| 80202 | 33 | 13 | $170.46 | |
| 86431 | 55 | 41 | $148.91 | |
| 86695 | 17 | 17 | $146.25 | |
| 84144 | 13 | 13 | $144.56 | |
| 85007 | 86 | 69 | $117.95 | |
| 84450 | 93 | 64 | $104.42 | |
| 85384 | 15 | 12 | $95.19 | |
| 84703 | 14 | 12 | $74.30 | |
| 85004 | 16 | 16 | $70.98 | |
| 82040 | 111 | 74 | $62.99 | |
| 80156 | 28 | 26 | $46.32 | |
| 84075 | 55 | 34 | $44.78 | |
| 85048 | 41 | 29 | $43.38 | |
| 82465 | 16 | 12 | $39.99 | |
| 84484 | 15 | 12 | $11.10 | |
| 80162 | 36 | 25 | $0.00 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 12 | 12 | $0.00 |
| S3600 | Stat laboratory request (situations other than s3601) | 202 | 194 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 52 | 51 | $0.00 |
| 80185 | 39 | 27 | $0.00 | |
| 80178 | 17 | 12 | $0.00 |